Canada markets closed

Pacific Biosciences of California, Inc. (PACB)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
10.11-0.24 (-2.32%)
At close: 01:00PM EST
10.20 +0.09 (+0.89%)
After hours: 04:08PM EST

Pacific Biosciences of California, Inc.

1305 O’Brien Drive
Menlo Park, CA 94025
United States
650 521 8000
https://www.pacb.com

Sector(s)Healthcare
IndustryMedical Devices
Full Time Employees728

Key Executives

NameTitlePayExercisedYear Born
Mr. Christian O. Henry M.B.A.Pres, CEO & Director1.42MN/A1968
Ms. Susan G. KimChief Financial Officer671.49kN/A1976
Mr. Mark Van OeneChief Operating Officer1.12MN/A1973
Dr. Denis Zaccarin Ph.D.Sr. VP of Product Devel.510.77k4.34M1966
Dr. Stephen TurnerCo-Founder & CTON/AN/A1968
Ms. Michele Farmer CPAVP & Chief Accounting OfficerN/AN/A1980
Dr. Jonas Korlach Ph.D.Chief Scientific OfficerN/AN/AN/A
Trevin RardHead of Investor RelationsN/AN/AN/A
Dr. Brett Atkins J.D., Ph.D.Gen. Counsel & Corp. Sec.N/AN/AN/A
Ms. Natalie WelchChief People OfficerN/AN/AN/A
Amounts are as of December 31, 2021 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits designed for specific workflow, such as template preparation kit to convert DNA into SMRTbell double-stranded DNA library formats, including molecular biology reagents, such as ligase, buffers, and exonucleases. It also offers binding kits, such as modified DNA polymerase used to bind SMRTbell libraries to the polymerase in preparation for sequencing; and sequencing kits comprise reagents required for on-instrument, real-time sequencing, including the phospholinked nucleotides. The company serves research institutions; commercial laboratories; genome centers; public health labs, hospitals and clinical research institutes, contract research organizations, and academic institutions; pharmaceutical companies; and agricultural companies. It markets its products through a direct sales force in North America and Europe, as well as through distribution partners in Asia, Europe, the Middle East, Africa, and Latin America. Pacific Biosciences of California, Inc. has a development and commercialization agreement with Invitae Corporation. The company was formerly known as Nanofluidics, Inc. and changed its name to Pacific Biosciences of California, Inc. in 2005. Pacific Biosciences of California, Inc. was incorporated in 2000 and is headquartered in Menlo Park, California.

Corporate Governance

Pacific Biosciences of California, Inc.’s ISS Governance QualityScore as of November 1, 2022 is 4. The pillar scores are Audit: 7; Board: 3; Shareholder Rights: 3; Compensation: 6.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.